207 related articles for article (PubMed ID: 20462855)
1. Antiangiogenic activity of ursolic acid.
Kanjoormana M; Kuttan G
Integr Cancer Ther; 2010 Jun; 9(2):224-35. PubMed ID: 20462855
[TBL] [Abstract][Full Text] [Related]
2. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
Thejass P; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
[TBL] [Abstract][Full Text] [Related]
4. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice.
Sunila ES; Kuttan G
Int Immunopharmacol; 2006 May; 6(5):733-41. PubMed ID: 16546703
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic activity of Andrographis paniculata extract and andrographolide.
Sheeja K; Guruvayoorappan C; Kuttan G
Int Immunopharmacol; 2007 Feb; 7(2):211-21. PubMed ID: 17178389
[TBL] [Abstract][Full Text] [Related]
6. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
7. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic activity of Diallyl Sulfide (DAS).
Thejass P; Kuttan G
Int Immunopharmacol; 2007 Mar; 7(3):295-305. PubMed ID: 17276887
[TBL] [Abstract][Full Text] [Related]
9. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
Guruvayoorappan C; Kuttan G
Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
[TBL] [Abstract][Full Text] [Related]
10. Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals.
Leyon PV; Kuttan G
Int Immunopharmacol; 2004 Dec; 4(13):1569-75. PubMed ID: 15454110
[TBL] [Abstract][Full Text] [Related]
11. Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Oct; 668(3):450-8. PubMed ID: 21839074
[TBL] [Abstract][Full Text] [Related]
12. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2008; 7(3):173-82. PubMed ID: 19066126
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.
Hamsa TP; Kuttan G
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):488-97. PubMed ID: 21058930
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
16. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
Siveen KS; Kuttan G
Can J Physiol Pharmacol; 2011 Oct; 89(10):691-703. PubMed ID: 21905822
[TBL] [Abstract][Full Text] [Related]
17. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
19. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
Hamsa TP; Kuttan G
Drug Chem Toxicol; 2012 Jan; 35(1):57-70. PubMed ID: 22145808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
